V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009901 | 270017863 | 1.71 | 90.1 | Curative (C) | 2017-07-05 | 2017-07-06 | null | N | N | 270021603 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270009902 | 270019484 | 1.68 | 70.5 | Curative (C) | 2016-09-30 | 2016-09-30 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 270021606 | NOT MATCHED |
| 270009903 | 270019484 | 1.85 | 62.2 | Curative (C) | 2015-02-15 | 2015-02-15 | Bortezomib +/- Dexamethasone | 02 | N | 270021606 | ETOPOSIDE |
| 270009904 | 270019484 | 1.88 | 53.5 | Palliative (P) | 2015-11-25 | 2015-11-27 | Vinblastine | 02 | N | 270021606 | CAPECITABINE + CISPLATIN |
| 270009905 | 270019484 | 1.73 | 63.3 | Curative (C) | 2016-03-14 | 2016-03-18 | PMitCEBO | 2 | N | 270021606 | ABVD R |
| 270009906 | 270005829 | 1.85 | null | Curative (C) | 2017-11-06 | 2017-11-22 | Rituximab | N | N | 270021638 | BRENTUXIMAB |
| 270009907 | 270012874 | null | 102 | Curative (C) | 2015-10-04 | 2015-11-07 | CVP R | null | N | 270021657 | CVP R |
| 270009908 | 270012874 | 1.83 | 65.6 | Disease modification (D) | 2016-05-24 | 2016-05-28 | R GCVP | 02 | N | 270021657 | ECHELON-1 TRIAL |
| 270009909 | 270005830 | 1.6 | 46 | Disease modification (D) | 2013-10-21 | 2013-11-15 | CHOP | N | null | 270021666 | CHOP |
| 270009910 | 270005830 | 1.7 | 73.4 | null | 2014-07-19 | 2014-07-20 | CVP R | 02 | null | 270021666 | NOT MATCHED |
| 270009911 | 270005830 | 1.67 | 69 | null | 2015-09-21 | 2015-09-21 | Vinblastine | 2 | N | 270021666 | ABVD R |
| 270009912 | 270005830 | 1.73 | 59 | Disease modification (D) | 2016-05-20 | 2016-06-07 | Rituximab | N | Y | 270021666 | NOT MATCHED |
| 270009913 | 270005831 | 1.55 | 75.5 | Adjuvant (A) | 2014-11-24 | 2015-05-11 | null | N | N | 270021686 | CVP R |
| 270009914 | 270005832 | 1.63 | 68.1 | Palliative (P) | 2016-03-17 | 2016-04-01 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | Y | N | 270021698 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270009915 | 270005832 | 1.8 | null | Disease modification (D) | 2015-11-25 | 2015-12-01 | DHAP | N | N | 270021698 | CVP R |
| 270009916 | 270005832 | null | null | Curative (C) | 2015-12-01 | 2015-12-03 | CVP R | N | null | 270021698 | NOT MATCHED |
| 270009917 | 270005833 | null | 86 | Curative (C) | 2017-11-26 | 2017-12-02 | DHAP | null | N | 270021726 | ABVD R |
| 270009918 | 270005834 | null | null | Palliative (P) | null | 2017-05-22 | Rituximab | null | null | 270021735 | NOT MATCHED |
| 270009919 | 270005835 | 1.76 | 88.1 | Palliative (P) | 2015-01-12 | 2015-01-25 | ABVD R | 02 | N | 270021743 | RITUXIMAB |
| 270009920 | 270005835 | 1.78 | 90.4 | Curative (C) | 2017-07-14 | 2017-07-20 | Rituximab | N | N | 270021743 | VINBLASTINE |
| 270009921 | 270005836 | 1.78 | 68 | Disease modification (D) | 2016-09-22 | 2016-09-29 | CHOP - 21 days | 02 | N | 270021753 | BRENTUXIMAB |
| 270009922 | 270005837 | 1.66 | 64.2 | Not known (9) | 2016-10-11 | 2016-10-27 | Rituximab | N | N | 270021755 | NOT MATCHED |
| 270009923 | 270005838 | 1.67 | 67.2 | Curative (C) | 2017-08-08 | 2017-08-14 | CVP R | N | N | 270021768 | CVP R |
| 270009924 | 270012878 | 1.76 | 75 | Curative (C) | 2018-05-09 | 2018-05-09 | LOPP | Y | N | 270021774 | NOT MATCHED |
| 270009925 | 270005839 | 1.65 | 76.95 | Curative (C) | 2013-11-14 | 2013-11-15 | LOPP | 2 | N | 270021781 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270009926 | 270005840 | 1.55 | 81.6 | Palliative (P) | 2018-03-05 | 2018-04-09 | CVP R | N | N | 270021783 | DHAP - R |
| 270009927 | 270005841 | 1.7 | null | null | 2017-01-08 | 2017-02-08 | CETUXIMAB + IRINOTECAN + MDG | Y | null | 270021785 | CVP R |
| 270009928 | 270012879 | null | 73.2 | null | 2017-05-30 | 2017-05-31 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 270021790 | ESHAP |
| 270009929 | 270005842 | 1.57 | 88.9 | Curative (C) | 2014-02-19 | 2014-02-19 | METHOTREXATE | N | N | 270021799 | PREDNISOLONE + VINBLASTINE + RITUXIMAB |
| 270009930 | 270005843 | 1.72 | 79.9 | Curative (C) | 2016-02-14 | 2016-02-15 | ESHAP | N | N | 270021802 | ECHELON 1 TRIAL |
| 270009931 | 270005844 | 1.85 | 65.4 | Curative (C) | 2016-09-06 | 2016-10-03 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | Y | 270021810 | BRENTUXIMAB |
| 270009932 | 270005844 | 1.7 | 55 | null | 2015-09-28 | 2015-10-02 | Vinblastine | 2 | N | 270021810 | IVE |
| 270009933 | 270005845 | 1.8 | 76.1 | Curative (C) | null | 2014-08-27 | null | N | null | 270021828 | SCOT TRIAL |
| 270009934 | 270005845 | 1.85 | 85.9 | Curative (C) | 2016-06-20 | 2016-06-23 | Bendamustine+Rituximab (1st Course) | 2 | N | 270021828 | CVP R |
| 270009935 | 270005846 | 1.59 | 0 | Curative (C) | 2016-05-30 | 2016-06-04 | ECHELON 1 TRIAL | N | N | 270021842 | RITUXIMAB |
| 270009936 | 270005846 | 1.58 | 56 | Curative (C) | 2014-04-17 | 2014-04-28 | ETOPOSIDE | 02 | N | 270021842 | ESHAP R |
| 270009937 | 270005846 | null | 92.3 | Palliative (P) | 2016-09-19 | 2016-09-27 | Bevacizumab + Oxaliplatin +MdG | N | null | 270021842 | CAPECITABINE + IRINOTECAN |
| 270009938 | 270005847 | 1.65 | 97 | Curative (C) | 2015-07-06 | 2015-07-10 | ABVD R | 02 | N | 270021876 | NOT MATCHED |
| 270009939 | 270005847 | 0 | 69.7 | Disease modification (D) | 2017-06-08 | 2017-06-18 | BEAM + FLUDARABINE | 02 | N | 270021876 | NOT MATCHED |
| 270009940 | 270005848 | 1.8 | -1 | Palliative (P) | 2017-06-24 | 2017-06-24 | Rituximab | N | null | 270021910 | IMATINIB |
| 270009941 | 270005848 | null | 78.75 | Curative (C) | 2013-08-29 | 2013-09-03 | CVP R | N | N | 270021910 | CETUXIMAB + RT |
| 270009942 | 270005849 | 1.66 | 105 | Curative (C) | 2015-11-03 | 2015-11-03 | GEMCITABINE + VINORELBINE | 02 | N | 270021926 | NOT MATCHED |
| 270009943 | 270005850 | 1.73 | null | Palliative (P) | 2011-07-01 | 2013-12-18 | CHOP - 21 days | Y | N | 270021929 | CHOP |
| 270009944 | 270005851 | 1.6 | 49.9 | Curative (C) | 2016-09-13 | 2016-09-13 | CVP R | 02 | N | 270021933 | ABVD R |
| 270009945 | 270005851 | null | 55.6 | Curative (C) | 2017-01-26 | 2017-01-30 | null | N | N | 270021933 | BREVITY TRIAL |
| 270009946 | 270016059 | 1.69 | 73 | Palliative (P) | 2015-12-29 | 2016-01-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 270021951 | CVP R |
| 270009947 | 270005852 | 1.68 | 81.7 | Palliative (P) | 2016-11-03 | 2016-11-16 | CVP | N | N | 270021967 | NOT MATCHED |
| 270009948 | 270005852 | 1.65 | 55.3 | Disease modification (D) | 2017-11-27 | 2017-11-27 | Bevacizumab + Cape + Oxali 21day | 2 | N | 270021967 | VINBLASTINE |
| 270009949 | 270005853 | 1.78 | null | Disease modification (D) | null | 2015-12-16 | CVP R | N | N | 270021972 | NOT MATCHED |
| 270009950 | 270005854 | 1.76 | 70.5 | Curative (C) | null | 2013-12-16 | CVP R | N | N | 270021973 | CARBOPLATIN |